Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Kiniksa Pharmaceuticals Ltd
Cash from Financing Activities
Kiniksa Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
Cash from Financing Activities
$1.5m
|
CAGR 3-Years
-81%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
See Also
What is Kiniksa Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
1.5m
USD
Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Cash from Financing Activities amounts to 1.5m USD.
What is Kiniksa Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-64%
Over the last year, the Cash from Financing Activities growth was -32%. The average annual Cash from Financing Activities growth rates for Kiniksa Pharmaceuticals Ltd have been -81% over the past three years , -64% over the past five years .